Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Amyris Inc (AMRS)

Amyris Inc (AMRS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 554,821
  • Shares Outstanding, K 204,731
  • Annual Sales, $ 152,560 K
  • Annual Income, $ -242,770 K
  • 60-Month Beta 0.45
  • Price/Sales 3.54
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.17
  • Number of Estimates 2
  • High Estimate -0.14
  • Low Estimate -0.20
  • Prior Year -0.51
  • Growth Rate Est. (year over year) +66.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.22 +22.07%
on 09/11/20
3.79 -28.50%
on 09/02/20
-0.59 (-17.88%)
since 08/25/20
3-Month
2.22 +22.07%
on 09/11/20
5.09 -46.76%
on 07/06/20
-1.33 (-32.92%)
since 06/25/20
52-Week
1.40 +93.57%
on 03/16/20
6.07 -55.35%
on 06/01/20
-2.08 (-43.42%)
since 09/25/19

Most Recent Stories

More News
4 Cannabis Stocks With the Runway Necessary to Reach New Highs

Cannabis is increasingly becoming accepted, and the market is growing. More states are legalizing it for medicinal and recreational purposes. New companies are emerging to serve this market. A potential,...

AMRS : 2.71 (+2.65%)
TPB : 28.54 (+0.60%)
VFF : 4.84 (+1.26%)
NEPT : 2.15 (-0.46%)
Amyris' Pipette Clean Baby Brand Selected By Alibaba For Accelerated Entry Into China For Singles' Day Sales

, /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients,...

AMRS : 2.71 (+2.65%)
Amyris Continues Market Adoption Of Its Sweetener With Approval By Health Canada

, /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural...

AMRS : 2.71 (+2.65%)
Amyris to Provide Business Overview And Update On Current Affairs At H.C. Wainwright 22nd Annual Global Investment Conference Today

, /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural...

AMRS : 2.71 (+2.65%)
Amyris Responds To LAVVAN's Filing Of Lawsuit On September 10, 2020

, /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural...

AMRS : 2.71 (+2.65%)
LAVVAN, Inc. Files $881 Million Federal Lawsuit Against Amyris, Inc. For Patent Infringement and Trade Secret Misappropriation

, /PRNewswire/ -- LAVVAN, Inc. ("LAVVAN") today announced that it has filed an lawsuit against biotechnology company Amyris, Inc. ("Amyris") (Nasdaq: AMRS) relating to Amyris's use of intellectual property...

AMRS : 2.71 (+2.65%)
Amyris to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 14, 2020

, /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients,...

AMRS : 2.71 (+2.65%)
New Strong Sell Stocks for September 4th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

AMRS : 2.71 (+2.65%)
EMAN : 1.1700 (-4.88%)
ASPS : 12.02 (-2.28%)
HESM : 15.14 (-1.05%)
ITMR : 21.61 (+2.03%)
Amyris Scales First Fermentation-Based Cannabinoid

, /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients,...

AMRS : 2.71 (+2.65%)
Users Marvel at Medical Cannabis' Myriad of Applications

, /PRNewswire/ -- Over the past several years, the cannabis industry has reached several milestones to almost completely redefine itself. Now, medical cannabis is predominantly being used to alleviate...

APHA : 4.23 (+0.24%)
MEDIF : 0.6398 (+6.46%)
LABS.TO : 0.84 (+5.00%)
NEPT.TO : 2.89 (unch)
AMRS : 2.71 (+2.65%)
ACB : 5.05 (-2.88%)
ACB.TO : 6.78 (-1.88%)
APHA.TO : 5.66 (+0.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Trade AMRS with:

Business Summary

Amyris INC is an integrated renewable products company applying industrial synthetic biology to genetically modify microorganisms to serve as living factories. Amyris designs these microorganisms to produce defined molecules for use as renewable chemicals and transportation fuels. The Company is engaged...

See More

Key Turning Points

2nd Resistance Point 2.78
1st Resistance Point 2.75
Last Price 2.71
1st Support Level 2.64
2nd Support Level 2.56

See More

52-Week High 6.07
Fibonacci 61.8% 4.29
Fibonacci 50% 3.74
Fibonacci 38.2% 3.18
Last Price 2.71
52-Week Low 1.40

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar